{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T07:10:07Z","timestamp":1746688207488,"version":"3.40.5"},"reference-count":32,"publisher":"Termedia Sp. z.o.o.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Med Sci"],"DOI":"10.5114\/aoms\/203474","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T06:36:51Z","timestamp":1746686211000},"source":"Crossref","is-referenced-by-count":0,"title":["No genetic causal links detected between antihypertensive medications and bladder cancer: insights from a trans-ancestry, drug-target Mendelian randomization analysis"],"prefix":"10.5114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9272-6236","authenticated-orcid":true,"given":"Xiao","family":"Xu","sequence":"first","affiliation":[{"name":"Nantong Health College of Jiangsu Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-4738","authenticated-orcid":false,"given":"Wen","family":"Gu","sequence":"additional","affiliation":[{"name":"Nantong First People's Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-391X","authenticated-orcid":false,"given":"Mohammad Ali","family":"Zakeri","sequence":"additional","affiliation":[{"name":"Rafsanjan University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-9575","authenticated-orcid":false,"given":"Yan Hai","family":"Chen","sequence":"additional","affiliation":[{"name":"Affiliated Nantong Hospital of Nanjing University of Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-8812","authenticated-orcid":false,"given":"Hai-Yan","family":"Hao","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Affiliated Hospital of Nantong University, Nantong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"ref-1432297","doi-asserted-by":"crossref","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Medicina (Kaunas) 2021; 57: 749.","DOI":"10.3390\/medicina57080749"},{"key":"ref-1432298","doi-asserted-by":"crossref","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017; 71: 96-108.","DOI":"10.1016\/j.eururo.2016.06.010"},{"key":"ref-1432299","doi-asserted-by":"crossref","unstructured":"Ahmadi H, Duddalwar V, Daneshmand S. Diagnosis and staging of bladder cancer. Hematol Oncol Clin North Am 2021; 35: 531-41.","DOI":"10.1016\/j.hoc.2021.02.004"},{"key":"ref-1432300","doi-asserted-by":"crossref","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1223-49.","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"ref-1432301","doi-asserted-by":"crossref","unstructured":"Sanghvi MM, Dhall E, Chahal CAA, et al. Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations. Eur Heart J Qual Care Clin Outcomes 2025; qcae117.","DOI":"10.1093\/ehjqcco\/qcae117"},{"key":"ref-1432302","doi-asserted-by":"crossref","unstructured":"Bettiol A, Lucenteforte E, Vannacci A, et al. Calcium channel blockers in secondary cardiovascular prevention and risk of acute events: real-world evidence from nested case-control studies on Italian hypertensive elderly. Clin Drug Investig 2017; 37: 1165-74.","DOI":"10.1007\/s40261-017-0576-2"},{"key":"ref-1432303","doi-asserted-by":"crossref","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev 2017; 1: CD002003.","DOI":"10.1002\/14651858.CD002003.pub5"},{"key":"ref-1432304","doi-asserted-by":"crossref","unstructured":"Chuang YW, Yu MC, Huang ST, et al. Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study. J Hypertens 2017; 35: 170-7.","DOI":"10.1097\/HJH.0000000000001130"},{"key":"ref-1432305","doi-asserted-by":"crossref","unstructured":"Jiang X, Castelao JE, Yuan JM, et al. Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis 2010; 31: 1964-71.","DOI":"10.1093\/carcin\/bgq173"},{"key":"ref-1432306","doi-asserted-by":"crossref","unstructured":"Xiong J, Yang L, Deng YQ, et al. The causal association between smoking, alcohol consumption and risk of bladder cancer: a univariable and multivariable Mendelian randomization study. Int J Cancer 2022; 151: 2136-43.","DOI":"10.1002\/ijc.34228"},{"key":"ref-1432307","doi-asserted-by":"crossref","unstructured":"Adolphe C, Xue A, Fard AT, Genovesi LA, Yang J, Wainwright BJ. Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility. Genome Med 2021; 13: 19.","DOI":"10.1186\/s13073-021-00827-9"},{"key":"ref-1432308","doi-asserted-by":"crossref","unstructured":"Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J 2023; 44: 4913-24.","DOI":"10.1093\/eurheartj\/ehad736"},{"key":"ref-1432309","doi-asserted-by":"crossref","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 2017; 32: 377-89.","DOI":"10.1007\/s10654-017-0255-x"},{"key":"ref-1432310","doi-asserted-by":"crossref","unstructured":"Smith GD, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23: R89-98.","DOI":"10.1093\/hmg\/ddu328"},{"key":"ref-1432311","doi-asserted-by":"crossref","unstructured":"Shoji-Asahina A, Usui T, Tabara Y. U-shaped association between blood pressure and all-cause mortality in older adults: the Shizuoka study. J Hum Hypertens 2025; 39: 66-71.","DOI":"10.1038\/s41371-024-00979-2"},{"key":"ref-1432312","doi-asserted-by":"crossref","unstructured":"Kishore SP, Blank E, Heller DJ, et al. Modernizing the World Health Organization list of essential medicines for preventing and controlling cardiovascular diseases. J Am Coll Cardiol 2018; 71: 564-74.","DOI":"10.1016\/j.jacc.2017.11.056"},{"key":"ref-1432313","doi-asserted-by":"crossref","unstructured":"Wang S, Xie L, Zhuang J, et al. Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai. BMC Cancer 2023; 23: 425.","DOI":"10.1186\/s12885-023-10849-8"},{"key":"ref-1432314","doi-asserted-by":"crossref","unstructured":"Copland E, Canoy D, Nazarzadeh M, et al. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. Lancet Oncol 2021; 22: 558-70.","DOI":"10.1016\/S1470-2045(21)00033-4"},{"key":"ref-1432315","doi-asserted-by":"crossref","unstructured":"Yang R, Zhang Y, Liao X, Yao Y, Huang C, Liu L. The relationship between anti-hypertensive drugs and cancer: anxiety to be resolved in urgent. Front Pharmacol 2020; 11: 610157.","DOI":"10.3389\/fphar.2020.610157"},{"key":"ref-1432316","doi-asserted-by":"crossref","unstructured":"Al-Wadei HA, Al-Wadei MH, Schuller HM. Prevention of pancreatic cancer by the beta-blocker propranolol. Anticancer Drugs 2009; 20: 477-82.","DOI":"10.1097\/CAD.0b013e32832bd1e3"},{"key":"ref-1432317","doi-asserted-by":"crossref","unstructured":"Forde A, Hemani G, Ferguson J. Review and further developments in statistical corrections for Winner\u2019s Curse in genetic association studies. PLoS Genet 2023; 19: e1010546.","DOI":"10.1371\/journal.pgen.1010546"},{"key":"ref-1432318","doi-asserted-by":"crossref","unstructured":"Zhao X, Wang Y, Liang C. Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis. Int Urol Nephrol 2022; 54: 1169-85.","DOI":"10.1007\/s11255-022-03173-w"},{"key":"ref-1432319","doi-asserted-by":"crossref","unstructured":"Zheng G, Chattopadhyay S, Sundquist J, Sundquist K, Ji J. Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study. Eur J Epidemiol 2024; 39: 535-48.","DOI":"10.1007\/s10654-024-01103-x"},{"key":"ref-1432320","doi-asserted-by":"crossref","unstructured":"Du K, Li A, Zhang CY, Li SM, Chen P. Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study. Front Pharmacol 2024; 15: 1448319.","DOI":"10.3389\/fphar.2024.1448319"},{"key":"ref-1432321","doi-asserted-by":"crossref","unstructured":"Xie Y, Xu P, Wang M, et al. Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis. Aging (Albany NY) 2020; 12: 1545-62.","DOI":"10.18632\/aging.102699"},{"key":"ref-1432322","doi-asserted-by":"crossref","unstructured":"Fan B, Schooling CM, Zhao JV. Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study. J Hum Hypertens 2023; 37: 1028-32.","DOI":"10.1038\/s41371-023-00835-9"},{"key":"ref-1432323","doi-asserted-by":"crossref","unstructured":"Chen CY. Mendelian randomization: methods for causal inference using genetic variants 2nd edition. Biometrics 2023; 79: 2771-2.","DOI":"10.1111\/biom.13874"},{"key":"ref-1432324","doi-asserted-by":"crossref","unstructured":"Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Meth Med Res 2007; 16: 309-30.","DOI":"10.1177\/0962280206077743"},{"key":"ref-1432325","doi-asserted-by":"crossref","unstructured":"Go\u0142awski M, Lejawa M, Banach M, J\u00f3\u017awiak J, Gierlotka M, Osadnik T. Association between Lp(a) and T2D: a Mendelian randomization study. Arch Med Sci 2024; 20: 1002-5.","DOI":"10.5114\/aoms\/187774"},{"key":"ref-1432326","doi-asserted-by":"crossref","unstructured":"Zhou J, Li Y, Lin Y, et al. The genetic causal association between hip or knee osteoarthritis and frailty: a two-sample Mendelian randomization analysis. Arch Med Sci 2024; 20: 938-46.","DOI":"10.5114\/aoms\/176741"},{"key":"ref-1432327","doi-asserted-by":"crossref","unstructured":"Zeng X, Juaiti M, Tang Y, Wang R, Liu D. Circulating micronutrients and risk of stroke: a Mendelian randomisation and cross-sectional observational study. Arch Med Sci 2024; 20: 2034-8.","DOI":"10.5114\/aoms\/199337"},{"key":"ref-1432328","doi-asserted-by":"crossref","unstructured":"Xu X, Wang SY, Wang R, et al. Association of antihypertensive drugs with psoriasis: a trans-ancestry and drug-target Mendelian randomization study. Vascul Pharmacol 2024; 154: 107284.","DOI":"10.1016\/j.vph.2024.107284"}],"container-title":["Archives of Medical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-203474-125079","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-203474-125079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T06:37:12Z","timestamp":1746686232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.archivesofmedicalscience.com\/No-genetic-causal-links-detected-between-antihypertensive-medications-and-bladder,203474,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":32,"alternative-id":["203474"],"URL":"https:\/\/doi.org\/10.5114\/aoms\/203474","relation":{},"ISSN":["1734-1922","1896-9151"],"issn-type":[{"value":"1734-1922","type":"print"},{"value":"1896-9151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}